Compositions and their uses directed to IL-4R alpha
US7507810B2 · kind B2 · utility
5Cited by
21References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 11, 2006 |
| Grant date | Mar 24, 2009 |
| Priority date | — |
| Expiry date | Oct 11, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/3525
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are compounds, compositions and methods for modulating the expression of IL-4R alpha in a cell, tissue or animal. Also provided are methods of target validation. Also provided are uses of disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and disorders related to expression of IL 4R-α, airway hyperresponsiveness, and/or pulmonary inflammation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.